José Federico
Díaz González
Catedrático de Universidad
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (11)
2023
-
Expert recommendations for the use of apremilast in psoriatic arthritis
Reumatologia Clinica, Vol. 19, Núm. 1, pp. 34-44
2021
-
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
Clinical Rheumatology, Vol. 40, Núm. 10, pp. 3979-3988
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
-
Update of the Position Paper of the Spanish Society of Rheumatology on Biosimilar Drugs
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 160-169
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2018
-
Status of Rheumatology in Spain in 2017: 2.0 Rheumatologists per 100,000 Population
Reumatologia Clinica
2015
-
Documento de posicionamiento de la Sociedad Española de Reumatología sobre fármacos biosimilares
Reumatologia Clinica, Vol. 11, Núm. 5, pp. 269-278
-
Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]
Seminars in Arthritis and Rheumatism
2012
-
¿Qué opinan los residentes de reumatología sobre su formación? Una encuesta de la Comisión Nacional de Reumatología
Reumatologia Clinica, Vol. 8, Núm. 1, pp. 27-30
2011
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology